SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-21-036512
Filing Date
2021-02-10
Accepted
2021-02-10 17:30:56
Documents
2
Group Members
NEW LEAF BPO ASSOCIATES I, L.P.NEW LEAF VENTURE MANAGEMENT III, L.L.C.RONALD M. HUNTVIJAY K. LATHI

Document Format Files

Seq Description Document Type Size
1 SC 13G d123486dsc13g.htm SC 13G 105104
2 EX-99.1 d123486dex991.htm EX-99.1 9270
  Complete submission text file 0001193125-21-036512.txt   116125
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Subject) CIK: 0001574232 (see all company filings)

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-91805 | Film No.: 21615276
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Biopharma Opportunities I, L.P. (Filed by) CIK: 0001625696 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G